arrow
H

Huigang Li

zhejiang university school of medicine
H指数:10
被引数:236
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Letter: Circulating DNA After Liver Transplantation: Distinguishing Tumour Recurrence From Allograft Injury. Authors' Reply

信函:肝移植后循环DNA:区分肿瘤复发与移植物损伤。作者回复

2026-10-170
OAAI
High immunosuppressants variability adversely affects post-transplant recurrence for patients with hepatocellular carcinoma

高免疫抑制剂变异性对肝细胞癌患者移植后复发产生不利影响

2026-09-020
OA
Advances in stimuli-responsive hydrogels for liver disease therapy: mechanisms, applications, and translational perspectives

刺激响应性水凝胶在肝脏疾病治疗中的研究进展:机制、应用及转化前景

2026-08-080
PRE
Review Article: Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine

综述:肝移植治疗肝细胞癌中的生物标志物:迈向精准医学

2026-07-300
PRE
Recurrence pattern for HBV-related HCC after liver transplantation in the antiviral era

抗病毒时代肝移植后HBV相关HCC的复发模式

2025-12-110
PRE
Hepatitis C Patient Education: Large Language Models Show Promise in Disseminating Guidelines

丙型肝炎患者教育:大型语言模型在传播指南方面显示出前景

2025-12-010
OA
HBV reactivation and its metabolomic profile after liver transplantation for hepatocellular carcinoma in non-alcoholic steatohepatitis

HBV再激活及非酒精性脂肪性肝炎肝移植术后肝癌的代谢组学特征

2025-10-010
PRE
A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma

基于血清TNFR2的模型可有效预测肝细胞癌术前的微血管浸润并分层肿瘤复发风险

2025-08-290
OAAI
Association between computed tomography-based adipose tissue parameters and liver transplant outcomes in patients with hepatocellular carcinoma

基于计算机断层扫描的脂肪组织参数与肝细胞癌患者肝脏移植结局的关联

2025-07-180
PRE
Mesenchymal circulating tumor cells as prognostic markers in HCC Post-Transplantation: Sirolimus as a potential therapeutic Modulator

循环间充质肿瘤细胞作为肝细胞癌移植后预后标志物:西罗莫司作为潜在的治疗调节剂

2025-05-150
PRE
Post-Transplant Hepatitis B Virus Reactivation and Survival in Hepatocellular Carcinoma Patients with Alcoholic Liver Disease

移植后乙型肝炎病毒再激活及酒精性肝病患者肝细胞癌患者的生存情况

2025-03-180
OAAI
Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma
2024-12-240
OAAI
FGF21 modulates immunometabolic homeostasis via the ALOX15/15-HETE axis in early liver graft injury
2024-10-030
OA
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma
2024-08-271
OA
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis
2024-08-230
OAAI
CircZCCHC2 (hsa_circ_0000854) promotes hepatocellular carcinoma progression through modulating miR-936/BTBD7 axis and activating Rho/ ROCK2 pathway
2024-06-011
OAAI
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study
2024-06-010
OAAI
FGF21-mediated autophagy: Remodeling the homeostasis in response to stress in liver diseases
2024-05-012
OAAI
Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China
2024-02-093
OAAI